Differential dependency of human cancer cells on vascular endothelial growth factor-mediated autocrine growth and survival

Cited 28 time in webofscience Cited 0 time in scopus
  • Hit : 368
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorLee, Jung-Whoiko
dc.contributor.authorLee, Jung-Sulko
dc.contributor.authorYu, Ha-Nako
dc.contributor.authorChoi, Kyung-Sunko
dc.contributor.authorChoi, Chul-Heeko
dc.date.accessioned2013-03-09T18:57:56Z-
dc.date.available2013-03-09T18:57:56Z-
dc.date.created2012-02-06-
dc.date.created2012-02-06-
dc.date.issued2011-10-
dc.identifier.citationCANCER LETTERS, v.309, no.2, pp.145 - 150-
dc.identifier.issn0304-3835-
dc.identifier.urihttp://hdl.handle.net/10203/97207-
dc.description.abstractAnalysis using the public microarray database Gene Expression Omnibus indicates significantly higher mRNA expression of VEGF and VEGFRs in colorectal cancer and high grade astrocytoma but not in hepatocellular carcinoma compared to normal tissue. Human malignant astrocytoma cell lines (U251-MG and U373-MG) and HT-1080 fibrosarcoma cells expressed relatively higher levels of VEGF and VEGFRs compared to hepatocellular and colorectal cancer cell lines. Administration of exogenous VEGF-A induced cell growth in a dose-dependent fashion in astrocytoma and fibrosarcoma cells but not in colorectal and hepatocellular cancer cells. The blockade of VEGF inhibited cell survival only in U251-MG, U373-MG and HT-1080 cells. These results collectively suggest the role of autocrine VEGF signaling in various cancer cells and provide a basis for the variable clinical responses to antiangiogenic therapy observed in different types of malignancies. (C) 2011 Elsevier Ireland Ltd. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER IRELAND LTD-
dc.subjectIN-VIVO-
dc.subjectVEGF EXPRESSION-
dc.subjectANGIOGENESIS-
dc.subjectKINASE-
dc.subjectNEUROPILIN-1-
dc.subjectRESISTANCE-
dc.subjectSTRATEGY-
dc.subjectTHERAPY-
dc.subjectSYSTEM-
dc.subjectTUMORS-
dc.titleDifferential dependency of human cancer cells on vascular endothelial growth factor-mediated autocrine growth and survival-
dc.typeArticle-
dc.identifier.wosid000294576400004-
dc.identifier.scopusid2-s2.0-79960840344-
dc.type.rimsART-
dc.citation.volume309-
dc.citation.issue2-
dc.citation.beginningpage145-
dc.citation.endingpage150-
dc.citation.publicationnameCANCER LETTERS-
dc.identifier.doi10.1016/j.canlet.2011.05.026-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.contributor.localauthorChoi, Chul-Hee-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorVEGF-
dc.subject.keywordAuthorBrain tumor-
dc.subject.keywordAuthorAngiogenesis-
dc.subject.keywordAuthorAutocrine-
dc.subject.keywordAuthorCell signaling-
dc.subject.keywordPlusIN-VIVO-
dc.subject.keywordPlusVEGF EXPRESSION-
dc.subject.keywordPlusANGIOGENESIS-
dc.subject.keywordPlusKINASE-
dc.subject.keywordPlusNEUROPILIN-1-
dc.subject.keywordPlusRESISTANCE-
dc.subject.keywordPlusSTRATEGY-
dc.subject.keywordPlusTHERAPY-
dc.subject.keywordPlusSYSTEM-
dc.subject.keywordPlusTUMORS-
Appears in Collection
BiS-Journal Papers(저널논문)
Files in This Item
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 28 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0